172 related articles for article (PubMed ID: 28959373)
1. Prevention of Invasive Aspergillosis in High-Risk Patients: Universal Versus Preemptive, Targeted Treatment.
Baddley JW; Apewokin S
Curr Fungal Infect Rep; 2008 Jun; 2():61-68. PubMed ID: 28959373
[TBL] [Abstract][Full Text] [Related]
2. [Invasive Aspergillosis in Hematological Patients].
Kimura S
Med Mycol J; 2016; 57(2):J77-88. PubMed ID: 27251320
[TBL] [Abstract][Full Text] [Related]
3. Novel preventative strategies against invasive aspergillosis.
Mantadakis E; Samonis G
Med Mycol; 2006 Sep; 44(Supplement_1):S327-S332. PubMed ID: 30408925
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Aspergillosis.
Jenks JD; Hoenigl M
J Fungi (Basel); 2018 Aug; 4(3):. PubMed ID: 30126229
[TBL] [Abstract][Full Text] [Related]
5. Treatment of invasive aspergillosis: Polyenes, echinocandins, or azoles?
Patterson TF
Med Mycol; 2006 Sep; 44(Supplement_1):S357-S362. PubMed ID: 30408929
[TBL] [Abstract][Full Text] [Related]
6. Invasive aspergillosis in developing countries.
Chakrabarti A; Chatterjee SS; Das A; Shivaprakash MR
Med Mycol; 2011 Apr; 49 Suppl 1():S35-47. PubMed ID: 20718613
[TBL] [Abstract][Full Text] [Related]
7. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.
Aguado JM; Vázquez L; Fernández-Ruiz M; Villaescusa T; Ruiz-Camps I; Barba P; Silva JT; Batlle M; Solano C; Gallardo D; Heras I; Polo M; Varela R; Vallejo C; Olave T; López-Jiménez J; Rovira M; Parody R; Cuenca-Estrella M; ; ; ;
Clin Infect Dis; 2015 Feb; 60(3):405-14. PubMed ID: 25336623
[TBL] [Abstract][Full Text] [Related]
8. [Update in the diagnostic and therapeutic approach of invasive aspergillosis in adult population].
Rabagliati R
Rev Chilena Infectol; 2018; 35(5):531-544. PubMed ID: 30725000
[TBL] [Abstract][Full Text] [Related]
9. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.
Cruciani M; Mengoli C; Loeffler J; Donnelly P; Barnes R; Jones BL; Klingspor L; Morton O; Maertens J
Cochrane Database Syst Rev; 2015 Oct; (10):CD009551. PubMed ID: 26424726
[TBL] [Abstract][Full Text] [Related]
10. Managing invasive aspergillosis in haematological patients in the era of resistance polymerase chain reaction and increasing triazole resistance: A modelling study of different strategies.
van de Peppel RJ; van der Beek MT; Visser LG; de Boer MGJ; Wallinga J
Int J Antimicrob Agents; 2019 Mar; 53(3):284-293. PubMed ID: 30395989
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis against Aspergillus is not perfect: problems and perils in stem cell transplantation.
Chandrasekar P
Med Mycol; 2009; 47 Suppl 1():S349-54. PubMed ID: 18663660
[TBL] [Abstract][Full Text] [Related]
12. Defining the diagnosis of invasive aspergillosis.
Chamilos G; Kontoyiannis DP
Med Mycol; 2006 Sep; 44(Supplement_1):S163-S173. PubMed ID: 30408899
[TBL] [Abstract][Full Text] [Related]
13. [The value of serum galactomannan antigen for detection of invasive aspergillosis in hematological patients].
Xie LP; Liu T; Meng WT; Zhou J
Zhonghua Nei Ke Za Zhi; 2006 Dec; 45(12):992-5. PubMed ID: 17326997
[TBL] [Abstract][Full Text] [Related]
14. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of invasive aspergillosis: recent developments and ongoing challenges.
Arvanitis M; Mylonakis E
Eur J Clin Invest; 2015 Jun; 45(6):646-52. PubMed ID: 25851301
[TBL] [Abstract][Full Text] [Related]
16. Improving the rates of Aspergillus detection: an update on current diagnostic strategies.
Jenks JD; Salzer HJF; Hoenigl M
Expert Rev Anti Infect Ther; 2019 Jan; 17(1):39-50. PubMed ID: 30556438
[TBL] [Abstract][Full Text] [Related]
17. Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group.
Herbrecht R; Patterson TF; Slavin MA; Marchetti O; Maertens J; Johnson EM; Schlamm HT; Donnelly JP; Pappas PG
Clin Infect Dis; 2015 Mar; 60(5):713-20. PubMed ID: 25414266
[TBL] [Abstract][Full Text] [Related]
18. Invasive aspergillosis: new insights into disease, diagnostic and treatment.
Karthaus M; Buchheidt D
Curr Pharm Des; 2013; 19(20):3569-94. PubMed ID: 23278538
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of invasive fungal diseases in neutropenic patients.
Almyroudis NG; Segal BH
Curr Opin Infect Dis; 2009 Aug; 22(4):385-93. PubMed ID: 19506476
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
